The federal contract IDV award SPE2D219D0070 was granted to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The IDV is a single-award indefinite delivery contract with a ceiling value of $45,158,494.05 and an ultimate completion date of May 28, 2024. Exelan Pharmaceuticals, a key supplier of generic and branded pharmaceutical products to various federal healthcare agencies, will deliver a diverse range of pharmaceutical items including ibuprofen, citalopram, albuterol, lisinopril, pregabalin, escitalopram oxalate, oseltamivir phosphate, prazosin HCL, sildenafil citrate, and zonisamide.
The original solicitation, issued by the Defense Logistics Agency, sought a supplier to provide Finasteride 1 MG and 5 MG tablets in bottle counts of 30, 90, and 500 under a firm-fixed price, requirements-type national contract. The resulting contract will allow the Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs to purchase these medications through DLA and VA prime vendor programs. The contract has a one-year base period and four one-year option periods, providing long-term, stable supply arrangements for these critical pharmaceutical products.
Generated 1/15/25, 9:11 AM